» Articles » PMID: 20874460

Aryl Hydrocarbon Receptor-null Allele Mice Have Hematopoietic Stem/progenitor Cells with Abnormal Characteristics and Functions

Overview
Journal Stem Cells Dev
Date 2010 Sep 30
PMID 20874460
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The aryl hydrocarbon receptor (AhR) belongs to the basic helix-loop-helix family of DNA-binding proteins that play a role in the toxicity and carcinogenicity of certain chemicals. The most potent ligand of the AhR known is 2,3,7,8-tetracholorodibenzo-p-dioxin. We previously reported tetrachlorodibenzo-p-dioxin-induced alterations in numbers and function of hematopoietic stem cells (HSCs). To better understand a possible role of the AhR in hematopoiesis, studies were undertaken in young adult AhR null-allele (KO) mice. These mice have enlarged spleens with increased number of cells from different lineages. Altered expression of several chemokine, cytokine, and their receptor genes were observed in spleen. The KO mice have altered numbers of circulating red and white blood cells, as well as a circadian rhythm-associated 2-fold increase in the number of HSC-enriched Lin(-)Sca-1(+)c-Kit(+) (LSK) cells in bone marrow. Primary cultures of KO HSCs and in vivo bromodeoxyuridine incorporation studies demonstrated an approximate 2-fold increased proliferative ability of these cells. More LSK cells from KO mice were in G(1) and S phases of cell cycle. Competitive repopulation studies also indicated significant functional changes in KO HSCs. LSK cells showed increased expression of Cebpe and decreased expression of several hematopoiesis-associated genes. These data indicate that AhR has a physiological and functional role in hematopoiesis. The AhR appears to play a role in maintaining the normal quiescence of HSCs.

Citing Articles

A Review of the Evidence for Tryptophan and the Kynurenine Pathway as a Regulator of Stem Cell Niches in Health and Disease.

Summers B, Broome S, Pang T, Mundell H, Koh Belic N, Tom N Int J Tryptophan Res. 2024; 17:11786469241248287.

PMID: 38757094 PMC: 11097742. DOI: 10.1177/11786469241248287.


The Aryl Hydrocarbon Receptor: Impact on the Tumor Immune Microenvironment and Modulation as a Potential Therapy.

Griffith B, Frankel T Cancers (Basel). 2024; 16(3).

PMID: 38339226 PMC: 10854841. DOI: 10.3390/cancers16030472.


Aryl hydrocarbon receptor activation alters immune cell populations in the lung and bone marrow during coronavirus infection.

Healey A, Fenner K, ODell C, Lawrence B Am J Physiol Lung Cell Mol Physiol. 2024; 326(3):L313-L329.

PMID: 38290163 PMC: 11281796. DOI: 10.1152/ajplung.00236.2023.


Indole-3-carboxaldehyde ameliorates ionizing radiation-induced hematopoietic injury by enhancing hematopoietic stem and progenitor cell quiescence.

Guan D, Yang Y, Pang M, Liu X, Li Y, Huang P Mol Cell Biochem. 2023; 479(2):313-323.

PMID: 37067732 DOI: 10.1007/s11010-023-04732-0.


Aryl Hydrocarbon Receptor: From Homeostasis to Tumor Progression.

Rejano-Gordillo C, Ordiales-Talavero A, Nacarino-Palma A, Merino J, Gonzalez-Rico F, Fernandez-Salguero P Front Cell Dev Biol. 2022; 10:884004.

PMID: 35465323 PMC: 9022225. DOI: 10.3389/fcell.2022.884004.


References
1.
Ema H, Takano H, Sudo K, Nakauchi H . In vitro self-renewal division of hematopoietic stem cells. J Exp Med. 2000; 192(9):1281-8. PMC: 2193353. DOI: 10.1084/jem.192.9.1281. View

2.
Cobaleda C, Schebesta A, Delogu A, Busslinger M . Pax5: the guardian of B cell identity and function. Nat Immunol. 2007; 8(5):463-70. DOI: 10.1038/ni1454. View

3.
Shtutman M, Zhurinsky J, Simcha I, Albanese C, DAmico M, Pestell R . The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A. 1999; 96(10):5522-7. PMC: 21892. DOI: 10.1073/pnas.96.10.5522. View

4.
Isufi I, Seetharam M, Zhou L, Sohal D, Opalinska J, Pahanish P . Transforming growth factor-beta signaling in normal and malignant hematopoiesis. J Interferon Cytokine Res. 2007; 27(7):543-52. DOI: 10.1089/jir.2007.0009. View

5.
Collins S . Retinoic acid receptors, hematopoiesis and leukemogenesis. Curr Opin Hematol. 2008; 15(4):346-51. DOI: 10.1097/MOH.0b013e3283007edf. View